Stocks climbed in the US on Monday as the market kicked off a holiday-shortened trading week, buoyed by strength in ...

The realm of politics, a seemingly endless tapestry woven from interwoven threads of ideology, policy, and power dynamics, ...

The Reserve Bank of Australia (RBA) has signaled its intention to maintain the current interest rate level until inflation ...

In Washington, the US Senate passed a bill to end a brief government shutdown that began after a missed midnight deadline.

Wesfarmers (ASX:WES) has announced an agreement to sell its Coregas business to a subsidiary of Nippon Sanso Holdings ...

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...

A round up of some stocks capturing attention this week, featuring INOVIQ, Tamboran Resources, Omni Bridgeway, Clarity Pharmaceuticals and Mesoblast.

Ventia (ASX:VNT) and Telstra (ASX:TLS) have signed a five-year strategic agreement. The agreement is expected to generate ...

Cleanaway Waste Management (ASX:CWY), Australia's largest provider of waste, recycling, and environmental services, has ...

Mesoblast (ASX:MSB) has received approval from the US Food and Drug Administration (FDA) for Ryoncil (remestemcel-L), making it the first mesenchymal stromal cell (MSC) therapy to be approved in the ...

Radiopharm Theranostics (ASX:RAD) has received approval from the Bellberry Human Research Ethics Committee to commence the Phase 1 clinical trial of its "177Lu-RAD202" therapy. Before a clinical trial ...